Alex J. Ambinder
Hematology Oncology | Oncology
401 North Broadway Street, Weinberg BLDG
Weinberg BLDG
Baltimore, MD 21287
Weinberg BLDG
Baltimore, MD 21287
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.
Journal: Leukemia & lymphoma
Published: February 15, 2026
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortium.
Journal: British journal of haematology
Published: September 11, 2025
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities.
Journal: Leukemia research
Published: June 25, 2025
Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemia.
Journal: EBioMedicine
Published: April 17, 2024
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Journal: Leukemia
Published: May 22, 2023
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: May 22, 2021
CV Risk Factors in Rural-to-Urban Migrants Versus the Urban-Born in South India.
Journal: Global heart
Published: July 06, 2017
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
Journal: Leukemia & lymphoma
Published: May 16, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026